Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v22-FR Version v11-EN
Language French English
Date Updated 2019-10-18 2018-12-20
Drug Identification Number 02468425 02468425
Brand name SHINGRIX SHINGRIX
Common or Proper name Herpes Zoster vaccine Herpes Zoster vaccine
Company Name GLAXOSMITHKLINE INC GLAXOSMITHKLINE INC
Ingredients VARICELLA-ZOSTER VIRUS GLYCOPROTEIN E ANTIGEN VARICELLA-ZOSTER VIRUS GLYCOPROTEIN E ANTIGEN
Strength(s) 50MCG 50MCG
Dosage form(s) SUSPENSION SUSPENSION
Route of administration INTRAMUSCULAR INTRAMUSCULAR
Packaging size 10's 10's
ATC code J07BK J07BK
ATC description
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date
Actual start date 2018-08-24 2018-08-24
Estimated end date Unknown Unknown
Actual end date
Shortage status Actual shortage Actual shortage
Company comments High demand for the drug coupled with the variable timing of supply shipments. Re-supply is ongoing with current inventory on allocation. High demand for the drug coupled with the variable timing of supply shipments. Supply unavailable. Limited supply available of Shingrix 1s.
Health Canada comments